Showing results (31-40 of 135) with videos related to
Sort By:
Pageof 14
Health Economics|April 29, 2024
Auditing the prescription drug consumer price index in a changing marketplaceAndrew L Hicks, Ernst R Berndt, Richard G FrankThe American Journal of Managed Care|August 18, 2022
Out-of-pocket spending for health care after COVID-19 hospitalizationKao-Ping Chua, Rena M Conti, Nora V BeckerBMC Public Health|January 29, 2025
Mortality in the families of children during the COVID-19 pandemic: evidence from a repeated cross-sectional study of children in the United StatesKao-Ping Chua, Rena M Conti, Nora V BeckerJournal of Law and the Biosciences|September 16, 2024
Industry price guarantees for publicly funded medicines: learning from Project NextGen for pandemics and beyondHolly Fernandez Lynch, Rena M Conti, Jorge L ContrerasJAMA Network Open|October 18, 2021
Assessment of Out-of-Pocket Spending for COVID-19 Hospitalizations in the US in 2020Kao-Ping Chua, Rena M Conti, Nora V BeckerThe Milbank Quarterly|June 18, 2005
Mental health policy and psychotropic drugsRichard G Frank, Rena M Conti, Howard H GoldmanAnnals of Hematology|March 28, 2015
Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EURena M Conti, William V Padula, Richard A LarsonJAMA Network Open|October 31, 2019
Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016Rena M Conti, Sayeh S Nikpay, Melinda B BuntinJournal of Pharmaceutical Policy and Practice|November 28, 2018
Generic prescription drug price increases: which products will be affected by proposed anti-gouging legislation?Rena M Conti, Kevin H Nguyen, Meredith B RosenthalHealth Affairs (Project Hope)|March 1, 2021
Spending For Orphan Indications Among Top-Selling Orphan Drugs Approved To Treat Common DiseasesKao-Ping Chua, Lauren E Kimmel, Rena M ContiPageof 14